Overview

• Williams says she began weekly injections in early 2024, about six months after giving birth and after stopping breastfeeding.
• She reports improved blood sugar and reduced knee pain since starting the medication, and says she has not experienced side effects.
• The specific drug was reported as Zepbound in some outlets, though she has otherwise referred to it broadly as a GLP-1 therapy.
• She describes the treatment as researched medical care rather than a shortcut, aligning with Ro’s effort to reduce stigma around GLP-1 use.
• Public reaction has been mixed, with online criticism over celebrity promotion and questions about her commercial ties alongside support for her transparency.